Effectiveness and safety of nab-paclitaxel/gemcitabine in locally advanced or metastatic pancreatic adenocarcinoma:

María José Nebot-Villacampa,Ricardo Zafra-Morales,Ascensión Alfaro-Olea,Raquel Marín-Gorricho,Andrea Casajús-Navasal,Moisés Uriarte Pinto

Effectiveness and safety of nab-paclitaxel/gemcitabine in locally advanced or metastatic pancreatic adenocarcinoma:

2019

María José Nebot-Villacampa
Ricardo Zafra-Morales
Ascensión Alfaro-Olea
Raquel Marín-Gorricho
Andrea Casajús-Navasal
Moisés Uriarte Pinto

BackgroundTreatment based on nab-paclitaxel plus gemcitabine is one of the standard treatments for locally advanced or metastatic pancreatic adenocarcinoma. Not much information is available about ...

Keywords:

Metastatic Pancreatic Adenocarcinoma
Internal medicine
Anesthesia
Gemcitabine
Oncology
Neutrophil to lymphocyte ratio
Medicine
Nab-paclitaxel
prognostic factor
locally advanced

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations